{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T11:00:37Z","timestamp":1787655637730,"version":"build-2736575974"},"reference-count":32,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,22]],"date-time":"2021-12-22T00:00:00Z","timestamp":1640131200000},"content-version":"am","delay-in-days":355,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejso.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Surgical Oncology"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.ejso.2020.10.012","type":"journal-article","created":{"date-parts":[[2020,10,14]],"date-time":"2020-10-14T03:25:23Z","timestamp":1602645923000},"page":"181-187","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Distribution of residual disease in the peritoneum following neoadjuvant chemotherapy in advanced epithelial ovarian cancer and its potential therapeutic implications"],"prefix":"10.1016","volume":"47","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9808-6898","authenticated-orcid":false,"given":"Aditi","family":"Bhatt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoual","family":"Bakrin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Praveen","family":"Kammar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanket","family":"Mehta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Snita","family":"Sinukumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Loma","family":"Parikh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sakina","family":"Shaikh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suniti","family":"Mishra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mrinal","family":"Mallaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9885-8600","authenticated-orcid":false,"given":"Vahan","family":"Kepenekian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nazim","family":"Benzerdjeb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2802-4974","authenticated-orcid":false,"given":"Olivier","family":"Glehen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.ejso.2020.10.012_bib1","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.ejso.2019.01.009","volume":"45","author":"Bhatt","year":"2019","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.ejso.2020.10.012_bib2","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.ygyno.2012.11.007","article-title":"Is perioperative visual estimation of intra- abdominal tumor spread reliable in ovarian cancer surgery after neoadjuvant chemotherapy?","volume":"128","author":"Hynninen","year":"2013","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ejso.2020.10.012_bib3","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1016\/S0140-6736(09)61338-6","article-title":"Ovarian cancer","volume":"374","author":"Hennessy","year":"2009","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.ejso.2020.10.012_bib4","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1007\/s13193-016-0501-9","article-title":"The role of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (hipec) in ovarian can- cer: a review","volume":"7","author":"Bhatt","year":"2016","journal-title":"Indian J Surg Oncol"},{"issue":"2","key":"10.1016\/j.ejso.2020.10.012_bib6","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.ygyno.2019.08.011","article-title":"Does the method of primary treatment affect the pattern of first recurrence in high-grade serous ovarian cancer?","volume":"155","author":"Himoto","year":"2019","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ejso.2020.10.012_bib7","series-title":"Surgical treatment of ovarian cancer, ovarian cancer - a clinical and translational update","author":"Minig","year":"2013"},{"issue":"3","key":"10.1016\/j.ejso.2020.10.012_bib8","first-page":"226","article-title":"Surgical staging of carcinoma of the ovaries","volume":"169","author":"Buchsbaum","year":"1989","journal-title":"Surg Gynecol Obstet"},{"issue":"6","key":"10.1016\/j.ejso.2020.10.012_bib9","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1159\/000313823","article-title":"Residual cancer stem cells after interval cytoreductive surgery following neoadjuvant chemotherapy could result in poor treatment outcomes for ovarian cancer","volume":"33","author":"Lim","year":"2010","journal-title":"Onkologie"},{"issue":"7","key":"10.1016\/j.ejso.2020.10.012_bib10","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1097\/IGC.0000000000001041","article-title":"European society of gynaecological oncology (ESGO) guidelines for ovarian cancer surgery","volume":"27","author":"D","year":"2017","journal-title":"Int J Gynecol Canc"},{"issue":"1","key":"10.1016\/j.ejso.2020.10.012_bib11","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/jso.25120","article-title":"A\u00a0collaborative surgical approach to upper and lower abdominal cytoreductive surgery in ovarian cancer","volume":"118","author":"Eng","year":"2018","journal-title":"J\u00a0Surg Oncol"},{"key":"10.1016\/j.ejso.2020.10.012_bib12","series-title":"Advances in peritoneal surface oncology. Springer-verlag, berlin heidelberg, Germany","first-page":"11","article-title":"The natural history of free cancer cells in the peritoneal cavity","author":"Yonemura","year":"2007"},{"key":"10.1016\/j.ejso.2020.10.012_bib13","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/978-1-4613-1247-5_23","article-title":"Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis","volume":"82","author":"Jacquet","year":"1996","journal-title":"Canc Treat Res"},{"issue":"12","key":"10.1016\/j.ejso.2020.10.012_bib14","doi-asserted-by":"crossref","first-page":"2398","DOI":"10.1016\/j.ejso.2019.07.019","article-title":"Pathological assessment of cytoreductive surgery specimens and its unexplored prognostic potential- a prospective multi-centric study","volume":"45","author":"Bhatt","year":"2019","journal-title":"Eur J Surg Oncol"},{"issue":"8","key":"10.1016\/j.ejso.2020.10.012_bib15","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1038\/modpathol.2015.77","article-title":"International collaboration on cancer reporting. Data set for reporting of ovary, fallopian tube and primary peritoneal carcinoma: recommendations from the International Collaboration on Cancer Reporting (ICCR)","volume":"28","author":"McCluggage","year":"2015","journal-title":"Mod Pathol"},{"key":"10.1016\/j.ejso.2020.10.012_bib16","doi-asserted-by":"crossref","DOI":"10.1245\/s10434-020-08234-x","article-title":"The pathologic peritoneal cancer index (PCI) strongly differs from the surgical PCI in peritoneal metastases arising from various primary tumors","author":"Bhatt","year":"2020","journal-title":"Ann Surg Oncol"},{"issue":"6","key":"10.1016\/j.ejso.2020.10.012_bib17","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.ejso.2016.03.015","article-title":"A\u00a0new internet tool to report peritoneal malignancy extent. PeRitOneal MalIgnancy stage evaluation (PROMISE) application","volume":"42","author":"Villeneuve","year":"2016","journal-title":"Eur J Surg Oncol"},{"issue":"22","key":"10.1016\/j.ejso.2020.10.012_bib18","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1200\/JCO.2014.60.5212","article-title":"Chemotherapy response score: development and val- idation of a system to quantify histopathologic response to neoad- juvant chemotherapy in tubo-ovarian high-grade serous carcino- ma","volume":"33","author":"B\u00f6hm","year":"2015","journal-title":"J\u00a0Clin Oncol"},{"issue":"1","key":"10.1016\/j.ejso.2020.10.012_bib19","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/00000658-199501000-00004","article-title":"Peritonectomy procedures","volume":"221","author":"Sugarbaker","year":"1995","journal-title":"Ann Surg"},{"issue":"5","key":"10.1016\/j.ejso.2020.10.012_bib20","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1245\/s10434-020-08208-z","article-title":"Extent of peritoneal resection for peritoneal metastases: looking beyond a complete cytoreduction","volume":"27","author":"Bhatt","year":"2020","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2020.10.012_bib21","series-title":"ASO author reflections: total parietal peritonectomy during interval cytoreductive surgery for advanced ovarian cancer\u2014proof-of-principle and analysis of morbidity","author":"Bhatt","year":"2020"},{"key":"10.1016\/j.ejso.2020.10.012_bib22","article-title":"Total parietal peritonectomy can be performed with acceptable morbidity in patients with advanced ovarian cancer following neoadjuvant chemotherapy: results from a prospective multi-centric study","author":"Bhatt","year":"2020","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2020.10.012_bib23","article-title":"A\u00a0comparison of outcomes following total and selective peritonectomy performed at the time of interval cytoreductive surgery for advanced serous epithelial ovarian, fallopian tube and primary peritoneal cancer - a study by INDEPSO","author":"Sinukumar","year":"2019","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.ejso.2020.10.012_bib24","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1002\/bjs.10527","article-title":"Evaluation of the peritoneal carcinomatosis index with CT and MRI","volume":"104","author":"Dohan","year":"2017","journal-title":"Br J Surg"},{"issue":"10","key":"10.1016\/j.ejso.2020.10.012_bib25","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1056\/NEJMoa0908806","article-title":"Neoadjuvant chemotherapy or primary surgery in stage IIIC or IV ovarian cancer","volume":"363","author":"Vergote","year":"2010","journal-title":"N\u00a0Engl J Med"},{"issue":"9990","key":"10.1016\/j.ejso.2020.10.012_bib26","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0140-6736(14)62223-6","article-title":"Primary chemotherapy versus primary surgery for newly diagnosed advanced ovarian cancer (CHORUS): an open-label, randomised, controlled, non-inferiority trial","volume":"386","author":"Kehoe","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.ejso.2020.10.012_bib27","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.ygyno.2011.08.014","article-title":"An analysis of patients with bulky advanced stage ovarian, tubal, and peritoneal carcinoma treated with primary debulking surgery (PDS) during an identical time period as the randomized EORTC- NCIC trial of PDS vs neoadjuvant chemotherapy (NACT)","volume":"124","author":"Chi","year":"2012","journal-title":"Gynecol Oncol"},{"issue":"Suppl 1","key":"10.1016\/j.ejso.2020.10.012_bib28","first-page":"57","article-title":"Impact of radicality versus timing of surgery in patients with advanced ovarian cancer (stage III C) undergoing CRS and HIPEC\u2014a retrospective study by INDEPSO Indian","volume":"10","author":"Bhatt","year":"2019","journal-title":"J\u00a0Surg Oncol"},{"key":"10.1016\/j.ejso.2020.10.012_bib29","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1056\/NEJMoa1808424","article-title":"A\u00a0randomized trial of lymphadenectomy in patients with advanced ovarian neoplasms","volume":"380","author":"Harter","year":"2019","journal-title":"N\u00a0Engl J Med"},{"issue":"9","key":"10.1016\/j.ejso.2020.10.012_bib30","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1097\/IGC.0000000000000007","article-title":"Ovarian cancer: sites of recurrence","volume":"23","author":"Amate","year":"2013","journal-title":"Int J Gynecol Canc"},{"issue":"8","key":"10.1016\/j.ejso.2020.10.012_bib31","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/j.ejso.2014.04.001","article-title":"Correlation between the extent of intraperitoneal disease and nodal metastasis in node-positive ovarian cancer patients","volume":"40","author":"Pereira","year":"2014","journal-title":"Eur J Surg Oncol"},{"issue":"Suppl 1","key":"10.1016\/j.ejso.2020.10.012_bib32","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1007\/s13193-019-00881-1","article-title":"Correlation between pelvic peritoneal disease and nodal metastasis in advanced OvarianCancer:can intraoperative findings define the need for systematic nodal dissection?","volume":"10","author":"Kammar","year":"2019","journal-title":"Indian J Surg Oncol"},{"key":"10.1016\/j.ejso.2020.10.012_bib33","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1097\/IGC.0000000000001366","article-title":"Prognostic value of pathologic chemotherapy response score in patients with ovarian cancer after neoadjuvant chemotherapy","volume":"28","author":"Michaan","year":"2018","journal-title":"Int J Gynecol Canc"}],"container-title":["European Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S074879832030843X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S074879832030843X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,15]],"date-time":"2025-08-15T16:05:36Z","timestamp":1755273936000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S074879832030843X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["S074879832030843X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejso.2020.10.012","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2020.04.02.20048702","asserted-by":"object"}]},"ISSN":["0748-7983"],"issn-type":[{"value":"0748-7983","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Distribution of residual disease in the peritoneum following neoadjuvant chemotherapy in advanced epithelial ovarian cancer and its potential therapeutic implications","name":"articletitle","label":"Article Title"},{"value":"European Journal of Surgical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejso.2020.10.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd, BASO ~ The Association for Cancer Surgery, and the European Society of Surgical Oncology. All rights reserved.","name":"copyright","label":"Copyright"}]}}